找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cardiovascular Risk in Type 2 Diabetes Mellitus; Assessment and Contr Nicolae Hancu Book 2003 Springer-Verlag Berlin Heidelberg 2003 cardio

[復(fù)制鏈接]
樓主: 太平間
41#
發(fā)表于 2025-3-28 15:06:59 | 只看該作者
Thom C. Potempa,Mary Fanett Wheelersuggested that Thiazolidinediones have potentially favorable effects on the diabetes associated proath-erogenic metabolic abnormalities including decrease in blood pressure, correction of diabetic dyslipidemia, improvement of fibrinolysis, and decrease in carotid artery intima-media thickness.In thi
42#
發(fā)表于 2025-3-28 19:32:03 | 只看該作者
43#
發(fā)表于 2025-3-29 00:26:12 | 只看該作者
The Heavy Burden of Cardiovascular Disease in Type 2 Diabetes, 2 diabetic patients and nondiabetic individuals. The correction of poor glycemic control reduces microvascular complications but its effect on the prevention of cardiovascular disease is more limited. Drug treatment of established cardiovascular disease in patients with type 2 diabetes should follo
44#
發(fā)表于 2025-3-29 06:01:08 | 只看該作者
Atherogenesis in Diabetes,in other known CVD risk factors. However, diabetic status appears to confer risk such that even after correction of other risk factors, the diabetic remains at high risk for macrovascular disease. The excess risk is so high that being diabetic is considered to place a patient in the same risk catego
45#
發(fā)表于 2025-3-29 10:51:15 | 只看該作者
Clinical Experience with Repaglinide, the First Prandial Glucose Regulator in Type 2 Diabetes,ke place during periods of low blood glucose. Data from comparative studies show that repaglinide reduces the risk of major hypoglycaemia by more than 50%, compared with sulphonylureas. This advantage may be even more marked when the patient is free to adopt a flexible/normal meal pattern. To reduce
46#
發(fā)表于 2025-3-29 13:17:16 | 只看該作者
47#
發(fā)表于 2025-3-29 19:04:25 | 只看該作者
Cardiovascular Risk in Obese Type 2 Diabetes Mellitus Patients,geted and multifactorial interventions. Structured programme as: therapy, education, monitoring, evaluation should be applied. Weight loss is a major therapeutic goal. Lifestyle optimization, through hypocaloric diet and physical activity and specific medication for obesity, are methods to be consid
48#
發(fā)表于 2025-3-29 23:09:26 | 只看該作者
The Hypertriglyceridemic Waist Concept: Implication for Evaluation and Management of Cardiovascular]. Android obesity has also been referred to as upper body obesity, central obesity or abdominal obesity. This condition is obviously more frequently observed in men than in women. Gynoid obesity, also referred to as lower body obesity or peripheral obesity, is the typical body fat distribution patt
49#
發(fā)表于 2025-3-30 00:28:44 | 只看該作者
50#
發(fā)表于 2025-3-30 05:41:51 | 只看該作者
The Prothrombotic Syndrome in Type 2 Diabetes: Assessment and Control,s are therefore relevant only in context with hyperreactive platelets and endothelial lesions or dysfunction. Correction of overweight and the improved metabolic control would however diminish the pathologically increased plasma levels of protrombothic hemostatic variables and in association with an
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 06:59
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
榕江县| 全州县| 郸城县| 阳谷县| 咸宁市| 孟州市| 石景山区| 迁安市| 海安县| 永和县| 扶沟县| 信丰县| 商丘市| 乳山市| 眉山市| 桃园县| 漠河县| 丰镇市| 哈巴河县| 涞水县| 河曲县| 繁峙县| 武定县| 贵州省| 个旧市| 太白县| 和硕县| 平南县| 余姚市| 徐水县| 宜春市| 安西县| 安仁县| 伊宁市| 濮阳市| 临沧市| 凤阳县| 华坪县| 兴和县| 松江区| 祥云县|